Dr. Vikram M. Varma, MD, FACEP
Emergency Medicine (Emergency Medicine Physician)
99 Route 37 W
Toms River, NJ 08755
Who else practices at this address →
Ocean County includes primary care (21% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 381
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Emergency Medicine Physician primary
NJ license 25MA07433400
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Monmouth Medical Center-Southern Campus Lakewood, NJ
Medical groups
- The Medical Group of New Jersey (314 clinicians)
- Central Jersey Urgent Care (80 clinicians)
- Allevate Medical Group LLC (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 381
- Services billed
- 690
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 204 | 177 |
| Established patient office or other outpatient visit, 20-29 minutes | 106 | 98 |
| New patient office or other outpatient visit, 45-59 minutes | 64 | 64 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 51 | 49 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 45 | 45 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 44 | 44 |
| New patient office or other outpatient visit, 30-44 minutes | 42 | 42 |
| Automated urinalysis test | 37 | 33 |
| Detection test by immunoassay with direct visual observation for influenza virus | 36 | 26 |
| X-ray of chest, 2 views | 31 | 29 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Doxycycline Monohydrate Other prescribers in Toms River, NJ | 40 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Toms River, NJ | 38 |
| Azithromycin Other prescribers in Toms River, NJ | 36 |
| Dexamethasone Other prescribers in Toms River, NJ | 36 |
| Methylprednisolone Other prescribers in Toms River, NJ | 32 |
| Cephalexin Other prescribers in Toms River, NJ | 30 |
| Fluticasone Propionate Other prescribers in Toms River, NJ | 28 |
| Prednisone Other prescribers in Toms River, NJ | 27 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Toms River, NJ | 18 |
| Amoxicillin Other prescribers in Toms River, NJ | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,549 in research payments for these studies, mostly to the institutions running them.
- An interventional phase 23 adaptive multicenter randomized doubleblind study to investigate efficacy and safety of oral sisunatovir compared with placebo in nonhospitalized symptomatic adults with respiratory syncytia…
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.